Pacific Biosciences' Q2 Product Revenue Jumps More Than 50 Percent | GenomeWeb

This article has been updated to include comments from a conference call.

NEW YORK (GenomeWeb) – Pacific Biosciences reported after the close of the market Thursday that its total second quarter 2016 revenues fell 17 percent compared to the second quarter of 2015.

The single-molecule sequencing technology firm reported total Q2 revenues of $20.7 million, down from $24.9 million in Q2 2015. It beat analysts' average estimate of $20.2 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.

Feb
23
Sponsored by
NuGEN

This webinar will discuss a project that sought to understand the parent-of-origin epigenetic mechanisms that regulate seed development in plants, with a particular emphasis on differentiating the maternal or paternal origin of epigenetics marks.

Mar
02
Sponsored by
VelaDx

This online seminar will highlight recent advances in the use of next-generation sequencing to detect drug-resistant mutations in patients with HIV or HCV.